Mine otse sisu juurde
Inimese saphenoosse veeni endoteelrakud (HSVEC)
Kude
Saphenous vein
Haigus
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Metastaaside asukoht
Not applicable (normal, non-tumorigenic primary cell)
Sünonüümid
HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121

Dokumendid

Inimese saphenoosse veeni endoteelrakud (HSVEC)

Primary cell · Toote number 300699

Venous endothelium for bypass graft research

€1,220.00ilma käibemaksu ja saatmiskuludeta

Kohandamine / Soovitused

Tellimusel valmistatud
1

01Üldine teave

Kirjeldus

Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.

HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.

Kude
Saphenous vein
Haigus
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Metastaaside asukoht
Not applicable (normal, non-tumorigenic primary cell)
Rakendused
Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
Sünonüümid
  • HSaVEC
  • HSVEC
  • Human saphenous vein endothelial cells
  • provitro 1210121

02Annetaja

Doonori vanus
Lot-specific (see CoA)
Etniline kuuluvus
Lot-specific (see CoA)

03Klassifikatsioon

Organism
Inimene
Sugu
Kogupõhine
Kasvuvõime
Järgija
GMO-staatus
GMO-vaba
GMO-staatuse üksikasjad
No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
Bioloogilise ohutuse tase
1

04Omadused

Morfoloogia
Cobblestone (endothelial)
Rakutüüp
Primary endothelial cells
Tuumorigeenne
No
Kahekordistumisaeg
approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)

05Käsitlemine ja kasvatamine

Kasvatuskeskkond
Endothelial Cell Growth Medium
Inkubatsiooni keskkond

37°C, 5% CO2, saturated humidity.

Toidulisandid
EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
Dissotsiatsioonireaktiiv
Subculture reagents as recommended on the certificate of analysis
Kolbi katmine
0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
Kultuuri edasikasvatamine

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Jagamissuhe
1 to 3
Külvitihedus
More than 6,000 cells/cm²
Vedeliku vahetus
24 hours after seeding, then every 48 to 72 hours
Taastumine pärast sulamist

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Sulatamine ja kasvatamine
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06Kvaliteedikontroll ja krüokonserveerimine

Viljatus

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Külmutuskeskkond
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Säilitamistingimused

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Tarne- ja kohaletoimetamistingimused

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Avaldumine ja vastuvõtlikkus

Pinnaantigeenid
CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
Ekspresseeritud retseptorid
VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)

08Tunnused

Viide
Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
NCBI maksukood
9606
Cellosaurus
Not assigned